Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Another French market introduction for Lescol

Nov. 22, 1996

Alkermes and Genentech expand collaboration for sustained-release human GH

Nov. 22, 1996

New impotence treatment deemed approvable by FDA

Nov. 22, 1996

Antidiabetic agents reported by Terumo

Nov. 22, 1996

First regulatory approval for impotence treatment

Nov. 21, 1996

Thrombopoietic activity of PEG-rHuMGDF established in cancer patients

Nov. 21, 1996

Solvay and TheraTech end HRT collaboration

Nov. 21, 1996

Arris/Merck & Co. osteoporosis collaboration

Nov. 21, 1996

French market introduction for Fractal

Nov. 21, 1996

HRT for preserving bone density in postmenopausal women

Nov. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...